WaveMan · Form 4
Liu Jean I insider trades
> Search tickers & screens ⌘K
LIVE

Liu Jean I insider trades

Liu Jean I has filed 37 Form 4s with the SEC that we hold, for SGEN (Chief Legal Officer), Erasca, Inc. (ERAS) (Director) and Connect Biopharma Holdings Ltd (CNTB) (Director). Across all of them we count 0 purchases worth $0 and 27 sales worth $13.7M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 14,457 shares of SGEN worth $2.6M, dated 2021-11-01. The first filing on our record is dated 2021-08-18 and the latest 2026-10-01.

SGEN

Chief Legal Officer · 26 filings · 27 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-08-16S, sale reported on Form 4718$111.0K2021-08-18
2021-08-31S, sale reported on Form 41,755$294.0K2021-09-02
2021-08-31S, sale reported on Form 41,893$317.1K2021-09-02
2021-11-01S, sale reported on Form 414,457$2.6M2021-11-03
2021-11-01S, sale reported on Form 48,776$1.6M2021-11-03
2021-11-01S, sale reported on Form 4753$131.8K2021-11-03
2021-11-01S, sale reported on Form 42,588$450.8K2021-11-03
2021-11-01S, sale reported on Form 42,080$359.8K2021-11-03
2021-11-01S, sale reported on Form 46,222$1.1M2021-11-03
2021-12-20S, sale reported on Form 4276$41.4K2021-12-22
2022-04-20S, sale reported on Form 4401$57.9K2022-04-22
2022-08-16S, sale reported on Form 4717$122.0K2022-08-17
2022-08-16S, sale reported on Form 4922$156.9K2022-08-17
2022-08-31S, sale reported on Form 41,893$292.3K2022-09-01
2022-08-31S, sale reported on Form 41,755$271.0K2022-09-01
2022-11-17S, sale reported on Form 48,333$1.1M2022-11-18
2023-01-04S, sale reported on Form 4475$64.1K2023-01-06
2023-01-05S, sale reported on Form 44,525$610.9K2023-01-06
2023-01-17S, sale reported on Form 4578$75.6K2023-01-19
2023-01-24S, sale reported on Form 45,000$675.1K2023-01-26
2023-02-16S, sale reported on Form 45,000$775.0K2023-02-21
2023-03-16S, sale reported on Form 45,000$999.5K2023-03-17
2023-04-06S, sale reported on Form 4174$35.8K2023-04-07
2023-04-17S, sale reported on Form 45,000$1.0M2023-04-19
2023-08-29S, sale reported on Form 4405$83.4K2023-08-30
2023-08-31S, sale reported on Form 41,893$391.8K2023-09-01
2023-09-21S, sale reported on Form 464$13.2K2023-09-22

Erasca, Inc. (ERAS)

Director · 8 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Connect Biopharma Holdings Ltd (CNTB)

Director · 3 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1241357) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms